Targeted therapy for squamous cell lung cancer
نویسندگان
چکیده
منابع مشابه
Targeted therapy for lung cancer.
To meet that challenge, an action plan [2] was designed by the European Respiratory Society (ERS) Thoracic Oncology Assembly officers in March 2010, which was subsequently approved and strongly welcomed by the ERS Executive Committee. Today the Thoracic Oncology Assembly has almost achieved all of the following. 1) To create a Task Force for a European initiative for quality management in lung ...
متن کاملTargeted therapy for non-small cell lung cancer.
The overall survival for the treatment of lung cancer patients is less than 15%, despite advances in chemotherapy, radiation therapy, and surgery, due to the inability to control metastatic disease. Over the past three decades, the genetics of lung cancer has been progressively delineated. Small molecule drugs or monoclonal antibodies have been developed that target and inactivate specific canc...
متن کاملTargeted cancer therapy: review article
Cancer is one of the most dangerous health problems of today modern societies which has an increasing rate especially in developing countries. There are many diverse ongoing treatment attempts trying to defeat cancer. Despite that, scientists have been unable to find a permanent cure for this disease. In many cases although there is a successful first response in patients, cancer cells are fina...
متن کاملPersonalized Targeted Therapy for Lung Cancer
Lung cancer has long been recognized as an extremely heterogeneous disease, since its development is unique in every patient in terms of clinical characterizations, prognosis, response and tolerance to treatment. Personalized medicine refers to the use of markers to predict which patient will most likely benefit from a treatment. In lung cancer, the well-developed epidermal growth factor recept...
متن کاملNon-small cell lung cancer: the era of targeted therapy.
In this review, the authors aim to provide an overview of current molecular targeted therapies for NSCLC, to propose an algorithm for clinical application of presently available treatment strategies, and to identify future directions for this important area of research. Historically, choice of treatment algorithm for the management of non-small cell lung cancer (NSCLC) has relied heavily upon h...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Lung Cancer Management
سال: 2012
ISSN: 1758-1966,1758-1974
DOI: 10.2217/lmt.12.40